Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ziegler

Showing results (251-260 of 338) with videos related to

Pageof 34
Sort By:
The Lancet. Child & Adolescent Health|October 2, 2021
Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry studySara Khan, Palma Solano-Paez, Tannu Suwal, et al.
Blood Advances|April 4, 2019
Germline deletion of <i>ETV6</i> in familial acute lymphoblastic leukemiaEvadnie Rampersaud, David S Ziegler, Ilaria Iacobucci, et al.
Journal for Immunotherapy of Cancer|September 27, 2022
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastomaTessa Gargett, Lisa M Ebert, Nga T H Truong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2016
Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and ProgressionNicholas F Evageliou, Michelle Haber, Annette Vu, et al.
NPJ Genomic Medicine|July 3, 2026
Family experiences of receiving treatment recommendations in a precision medicine trial for poor-prognosis childhood cancerKate Hetherington, Jacqueline D Hunter, Mark W Donoghoe, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 14, 2025
Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastomaKimberley M Hanssen, Jayne Murray, Ruby Pandher, et al.
Neuro-Oncology|February 12, 2025
High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeuticDannielle H Upton, Jie Liu, Sandra M George, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 24, 2024
Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [<sup>18</sup>F]FET PET, and TSPO PETLena Kaiser, S Quach, A J Zounek, et al.
Neuro-Oncology|February 11, 2022
Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG RegistryMargot A Lazow, Martijn T Nievelstein, Adam Lane, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 8, 2025
Neoadjuvant radiochemotherapy in patients with high-risk locally advanced cervical cancer-results of a clinical seriesS Donath, M A Schirmer, F Bremmer, et al.
Pageof 34

Showing results (251-260 of 338) with videos related to

Sort By:
Pageof 34
The Lancet. Child & Adolescent Health|October 2, 2021
Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry studySara Khan, Palma Solano-Paez, Tannu Suwal, et al.
Blood Advances|April 4, 2019
Germline deletion of <i>ETV6</i> in familial acute lymphoblastic leukemiaEvadnie Rampersaud, David S Ziegler, Ilaria Iacobucci, et al.
Journal for Immunotherapy of Cancer|September 27, 2022
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastomaTessa Gargett, Lisa M Ebert, Nga T H Truong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2016
Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and ProgressionNicholas F Evageliou, Michelle Haber, Annette Vu, et al.
NPJ Genomic Medicine|July 3, 2026
Family experiences of receiving treatment recommendations in a precision medicine trial for poor-prognosis childhood cancerKate Hetherington, Jacqueline D Hunter, Mark W Donoghoe, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 14, 2025
Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastomaKimberley M Hanssen, Jayne Murray, Ruby Pandher, et al.
Neuro-Oncology|February 12, 2025
High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeuticDannielle H Upton, Jie Liu, Sandra M George, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 24, 2024
Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [<sup>18</sup>F]FET PET, and TSPO PETLena Kaiser, S Quach, A J Zounek, et al.
Neuro-Oncology|February 11, 2022
Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG RegistryMargot A Lazow, Martijn T Nievelstein, Adam Lane, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 8, 2025
Neoadjuvant radiochemotherapy in patients with high-risk locally advanced cervical cancer-results of a clinical seriesS Donath, M A Schirmer, F Bremmer, et al.
Pageof 34